openPR Logo
Press release

Rectal Cancer Market Professional Survey Report: Key Players are Eli Lilly and Company, Merck & Co., Inc., Amgen, Inc., Novartis AG

06-15-2017 02:44 PM CET | Health & Medicine

Press release from: Transparency Market Research

Rectal Cancer Market Professional Survey Report: Key Players

Rectal cancer is a malignant disease in which cancer cells form in the tissues of the rectum. The digestive system takes in nutrients from foods consumed by the host and helps waste material pass out of the body through the anus. There are various causes that contribute to the occurrence of rectal cancer such as increasing age (mostly over 50), having certain family history of rectal cancer, history of polyps or colorectal cancer, high-fat diet consumption and smoking. The most common type of rectal cancer is adenocarcinoma and comprises the majority of all the cases relating to rectal cancer. Other rare forms of rectal cancer are lymphoma, carcinoid, and sarcoma. Rectal bleeding, diarrhea, not being able to vacate the bowel completely, constipation, weight loss, bowel obstruction, small diameter tools, abdominal pain and weakness are some of the most common symptoms of rectal cancer. The various stages of rectal cancer are:

Stage I: Tumor is located in the first or second layer of the rectum wall but have not spread out of the rectum itself.
Stage II: Tumor spreads in the mesorectum.
Stage III: Tumor penetrates and spreads in the lymph nodes but not in order parts of the body.
Stage IV: Tumor spreads to different parts of the body, distant organs and tissues such as the lever or the lungs. It has spread outside the rectal region and stage IV is also known as metastatic rectal cancer stage.

Obtain Report Details @ http://www.transparencymarketresearch.com/rectal-cancer-market.html

Rectal Cancer Market Segmentation

Based on the diagnosis, the rectal cancer market can be segmented as follows:

Digital rectal examination (DRE)
Rigid proctoscopy
Laboratory tests, i.e., carcinoembryonic antigen (CEA) test, complete blood count etc.
Screening tests, i.e., stool DNA screening, flexible sigmoidoscopy, computed tomography (CT) colonography
Imaging tests, i.e., CT scanning of abdomen, endorectal ultrasonography, pelvic magnetic resonance imaging (MRI)

Before the treatment of a patient diagnosed with rectal cancer begins, three vital points have to be taken into consideration, i.e., the extent to which the tumor has spread, the involvement of lymph nodes and whether the tumor has spread to different parts of the body or not.

Based on the treatments involved, the rectal cancer market can be segmented as follows:

Surgery: Radical resection is the most important surgical treatment for rectal cancer. Others include transanal excision, transanal microsurgery, and endocavity radiotherapy.
Adjuvant medical therapy: Various adjuvant medical management therapies include intraoperative radiation therapy, adjuvant chemotherapy, chemoradiation therapy and radioembolization.
Pharmacotherapy:
Antineoplastic agents (for instance, fluorouracil, leucovorin, panitumumab etc.)
Vaccines (quadrivalent papillomavirus vaccine)

Based on geographical locations, the rectal cancer market can be segmented into four major segments: North America, Europe, Asia-Pacific and Rest of the World (ROW). Out of these four regions, North America dominates the rectal cancer market followed by Europe. The major driving reasons for the growth of rectal cancer market are constantly increasing geriatric population, growing awareness about malignant effects of cancer amongst individuals, and increasing unhealthy lifestyle practices such as smoking and consumption of high fat content food. Asia-Pacific is one of the most lucrative markets for the growth of rectal cancer market and it is continuously growing at a steady rate. The advantageous factors which will contribute towards the augmentation of rectal cancer market in Asia-Pacific are high population density including the geriatric population, rapidly increasing demand for technologically advanced therapeutic treatment, and major government support for improved healthcare infrastructures such as hospitals and clinics.

Fill The Form To Gain Deeper Insights On This Market @ http://www.transparencymarketresearch.com/sample/sample.php?flag=B&rep_id=14954

Various pharmaceutical companies are constantly trying to come up with novel therapeutic drugs and surgeries for the treatment of rectal cancer. Some of the top major players operating in rectal cancer therapeutics market are Eli Lilly and Company, Merck & Co., Inc., Amgen, Inc., Novartis AG, AstraZeneca PLC, Peregrine Pharmaceuticals, Inc., AbbVie, Inc., Nanobiotix, GenVec, Inc.,and many others.

About Us
Transparency Market Research (TMR) is a global market intelligence company providing business information reports and services. The company’s exclusive blend of quantitative forecasting and trend analysis provides forward-looking insight for thousands of decision makers. TMR’s experienced team of analysts, researchers, and consultants use proprietary data sources and various tools and techniques to gather and analyze information.

Contact us:
Transparency Market Research
90 State Street,
Suite 700,
Albany
NY - 12207
United States
Tel: +1-518-618-1030
USA - Canada Toll Free 866-552-3453
Email: sales@transparencymarketresearch.com
Website: http://www.transparencymarketresearch.com/

This release was published on openPR.

Permanent link to this press release:

Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.

You can edit or delete your press release Rectal Cancer Market Professional Survey Report: Key Players are Eli Lilly and Company, Merck & Co., Inc., Amgen, Inc., Novartis AG here

News-ID: 579335 • Views: 226

More Releases from Transparency Market Research

Non-Woven Tapes Market to Witness an Outstanding Growth during 2021 - 2031
Non-Woven Tapes Market: An overview Non-woven tapes, being microporous in nature, have excellent permeability to air and moisture. They are easily tearable by hand and their relatively low total thickness implies that they can adjust to irregular surfaces. Having all these qualities in check, the non-woven tapes are being hugely utilized in the healthcare industry. The non-woven tapes are applicable for hygienic products, electronics and construction industry. Non-woven tapes are
Hardware Security Module (HSM) Market Sales Revenue, Grow Pricing and Industry G …
Hardware Security Module (HSM) Market: Overview According to a new market report published by Transparency Market Research the global hardware security module market is expected to reach a value of US$ 6,592.5 Mn by 2027 on account of rising security concerns across a number of industries. The market is projected to expand at a CAGR of 11.4% during the forecast period from 2020 to 2027. Growth of the hardware security
Hose Pump Market is estimated to cross US$ 1 Bn by 2031
Hose Pump Market: Introduction Transparency Market Research delivers key insights on the global hose pump market. In terms of revenue, the global hose pump market is estimated to expand at a CAGR of ~5% during the forecast period, owing to numerous factors regarding which TMR offers thorough insights and forecasts in the global hose pump market report. Obtain Report Details @ https://www.transparencymarketresearch.com/hose-pump-market.html In this market report, TMR predicts that the global hose pump
Coffee Machines Market Regional Growth Overview and Growth Factors Details by Re …
Coffee machines are appliances used to brew coffee. Coffee machines work on various brewing processes. The process in which coffee machines use coffee grounds which are located in a metal strainer inside the pipe is the most common process. Thus, coffee machines save time and directly affect the taste of the coffee. Its application includes household, office, and commercial consumption. Obtain Report Details @ https://www.transparencymarketresearch.com/coffee-machines-market.html There are various factors driving the global

All 5 Releases


More Releases for Rectal

Colon and Rectal Cancer Drugs Market Opportunity Analysis, 2018 – 2026
Colon and rectal cancer are often grouped together, as they have many common features. Rate of colorectal cancer is increasing among the millennials in the U.S. The American Cancer Society (ACS) estimates that there will be around 97,220 new cases of colon cancer and around 43,030 new cases of rectal cancer registered in the U.S. in 2018. Moreover, owing to increasing risk of colorectal cancer, in May 2018, ACS updated
Rectal Cancer - Pipeline Review, H2 2017
ReportsWorldwide has announced the addition of a new report title Rectal Cancer - Pipeline Review, H2 2017 to its growing collection of premium market research reports. Summary Global Markets Direct's latest Pharmaceutical and Healthcare disease pipeline guide Rectal Cancer - Pipeline Review, H2 2017, provides an overview of the Rectal Cancer (Oncology) pipeline landscape. Rectal cancer affects the lower part of the colon, which connects the large bowel to the anus. The risk
Rectal Cancer-Pipeline Review H2 2017
ReportsWeb.com has announced the addition of the “Rectal Cancer-Pipeline Review H2 2017” this report provides an overview of the Rectal Cancer (Oncology) pipeline landscape. Rectal cancer affects the lower part of the colon, which connects the large bowel to the anus. The risk factors for developing rectal cancer are increasing age, smoking, family history of colon or rectal cancer, high-fat diet and/or a diet mostly from animal sources and personal or
Rectal Cancer Market : Dynamics, Segments and Supply Demand 2016-2024
Rectal cancer is a malignant disease in which cancer cells form in the tissues of the rectum. The digestive system takes in nutrients from foods consumed by the host and helps waste material pass out of the body through the anus. There are various causes that contribute to the occurrence of rectal cancer such as increasing age (mostly over 50), having certain family history of rectal cancer, history of polyps or colorectal
Rectal Cancer Market Is Expected To Profits by 2016 - 2024
Rectal cancer is a malignant disease in which cancer cells form in the tissues of the rectum. The digestive system takes in nutrients from foods consumed by the host and helps waste material pass out of the body through the anus. There are various causes that contribute to the occurrence of rectal cancer such as increasing age (mostly over 50), having certain family history of rectal cancer, history of polyps or colorectal
Rectal Cancer Market 2016-2024 : Technological Breakthroughs & Competitive Lands …
Rectal cancer is a malignant disease in which cancer cells form in the tissues of the rectum. The digestive system takes in nutrients from foods consumed by the host and helps waste material pass out of the body through the anus. There are various causes that contribute to the occurrence of rectal cancer such as increasing age (mostly over 50), having certain family history of rectal cancer, history of polyps